Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Fraser Institute News Release: Ottawa’s push for lower drug costs may hurt patients, stunt innovation

GlobeNewswire Thursday, 24 January 2019
VANCOUVER, British Columbia, Jan. 24, 2019 (GLOBE NEWSWIRE) -- The federal government’s plan to lower prescription drug prices could impede access and thus limit the benefits of life-saving drugs and discourage innovation, finds a new study released today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.The Patented Medicine Prices Review Board (PMPRB)—a federal body that regulates the prices of all patented medicines in Canada—is expected to implement new rules to regulate lower drug prices.

“Ottawa’s new cost-containment plans for pharmaceuticals—while driving prices down—may also unfortunately lead to reduced access to new drugs for Canadian patients and even deter the investment by pharmaceutical companies needed to discover new medicines,” said Bacchus Barua, associate director of health policy studies at the Fraser Institute and co-author of *Pharmaceutical Regulation, Innovation, and Access to New Drugs: An International Perspective*.

The study raises serious concerns about the underlying process used to regulate drug prices including a bias towards cost savings rather than extending life.

Specifically, the study finds that introducing what is known as “cost-effective analysis” into the pricing of new drugs may underestimate the true benefit of new drug therapies, particularly biologics and other personalized drug treatments, by narrowing the scope of potential benefits.

“The federal government is potentially on a path that will limit access of Canadians to new life-saving drugs, while further discouraging the discovery of new medicines,” said Steven Globerman, professor emeritus at Western Washington University, Fraser Institute senior fellow and study co-author.

This is the third study in a series on Canada’s pharmaceutical drug-pricing policy reforms.

*MEDIA CONTACTS*:
Steven Globerman, Senior Fellow
Fraser Institute

Bacchus Barua, Associate Director, Health Policy Studies
Fraser Institute

To arrange media interviews or for more information, please contact:
Bryn Weese, Media Relations Specialist, Fraser Institute
(604) 688-0221 ext. 589
bryn.weese@fraserinstitute.org
                 Follow the Fraser Institute on Twitter* | *Like us on Facebook

The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of think-tanks in 87 countries. Its mission is to improve the quality of life for Canadians, their families and future generations by studying, measuring and broadly communicating the effects of government policies, entrepreneurship and choice on their well-being. To protect the Institute’s independence, it does not accept grants from governments or contracts for research. Visit www.fraserinstitute.org
0
shares
ShareTweetSavePostSend
 

You Might Like


Tweets about this


Other recent news in Press Releases

Kornit Digital appoints Andy Yarrow as PRESIDENT of Asia PacificSelf Point Introduces e-Commerce Encompassing Mobile-First Stores, Fulfillment and Delivery SOFTWARE During The NGA Show
Proshred MINNESOTA Wins Bid from the State of MINNESOTA and Gains Access to the Vast Network of Cooperative Purchasing Venture MembersAustralia Zoo Celebrates STEVE IRWIN's Legacy with Google Partnership and More
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest